Yongjian Qi1,2, Bin Li1,2, Yinxian Wen1,2, Xu Yang2, Biao Chen1,2, Zheng He1,2, Zhe Zhao1, Jacques Magdalou3, Hui Wang4,5, Liaobin Chen6,7. 1. Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. 2. Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, 430071, China. 3. UMR 7561 CNRS-Université de Lorraine, Faculté de Médicine, Vandoeuvre-lès-Nancy, France. 4. Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, 430071, China. wanghui19@whu.edu.cn. 5. Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan, 430071, China. wanghui19@whu.edu.cn. 6. Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. lbchen@whu.edu.cn. 7. Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan, 430071, China. lbchen@whu.edu.cn.
Abstract
BACKGROUND: Epidemiological investigation and our previous reports indicated that osteoarthritis had a fetal origin and was closely associated with intrauterine growth retardation (IUGR). Human Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) could be programmable to "remember" early-life stimuli. Here, we aimed to explore an early-warning biomarker of fetal-originated adult osteoarthritis in the WJ-MSCs. METHODS: Firstly, two kinds of WJ-MSCs were applied to evaluate their chondrogenic potential in vitro through inducing chondrogenic differentiation as the first step of our strategy, one from newborns with IUGR and the other from normal newborns but treated with excessive cortisol during differentiation to simulate the excessive maternal glucocorticoid in the IUGR newborns. As for the second step of the strategy, the differentiated WJ-MSCs were treated with interleukin 1β (IL-1β) to mimic the susceptibility to osteoarthritis. Then, the expression and histone acetylation levels of transforming growth factor β (TGFβ) signaling pathway and the expression of histone deacetylases (HDACs) were quantified, with or without cortisol receptor inhibitor RU486, or HDAC4 inhibitor LMK235. Secondly, the histone acetylation and expression levels of TGFβRI were further detected in rat cartilage and human umbilical cord from IUGR individuals. RESULTS: Glycosaminoglycan content and the expression levels of chondrogenic genes were decreased in the WJ-MSCs from IUGR, and the expression levels of chondrogenic genes were further reduced after IL-1β treatment, while the expression levels of catabolic factors were increased. Then, serum cortisol level from IUGR individuals was found increased, and similar changes were observed in normal WJ-MSCs treated with excessive cortisol. Moreover, the decreased histone 3 lysine 9 acetylation (H3K9ac) level of TGFβRI and its expression were observed in IUGR-derived WJ-MSCs and normal WJ-MSCs treated with excessive cortisol, which could be abolished by RU486 and LMK235. At last, the decreased H3K9ac level of TGFβRI and its expression were further confirmed in the cartilage of IUGR rat offspring and human umbilical cords from IUGR newborn. CONCLUSIONS: WJ-MSCs from IUGR individuals displayed a poor capacity of chondrogenic differentiation and an increased susceptibility to osteoarthritis-like phenotype, which was attributed to the decreased H3K9ac level of TGFβRI and its expression induced by high cortisol through GR/HDAC4. The H3K9ac of TGFβRI in human umbilical cord could be a potential early-warning biomarker for predicting neonatal cartilage dysplasia and osteoarthritis susceptibility.
BACKGROUND: Epidemiological investigation and our previous reports indicated that osteoarthritis had a fetal origin and was closely associated with intrauterine growth retardation (IUGR). Human Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) could be programmable to "remember" early-life stimuli. Here, we aimed to explore an early-warning biomarker of fetal-originated adult osteoarthritis in the WJ-MSCs. METHODS: Firstly, two kinds of WJ-MSCs were applied to evaluate their chondrogenic potential in vitro through inducing chondrogenic differentiation as the first step of our strategy, one from newborns with IUGR and the other from normal newborns but treated with excessive cortisol during differentiation to simulate the excessive maternal glucocorticoid in the IUGR newborns. As for the second step of the strategy, the differentiated WJ-MSCs were treated with interleukin 1β (IL-1β) to mimic the susceptibility to osteoarthritis. Then, the expression and histone acetylation levels of transforming growth factor β (TGFβ) signaling pathway and the expression of histone deacetylases (HDACs) were quantified, with or without cortisol receptor inhibitor RU486, or HDAC4 inhibitor LMK235. Secondly, the histone acetylation and expression levels of TGFβRI were further detected in rat cartilage and human umbilical cord from IUGR individuals. RESULTS:Glycosaminoglycan content and the expression levels of chondrogenic genes were decreased in the WJ-MSCs from IUGR, and the expression levels of chondrogenic genes were further reduced after IL-1β treatment, while the expression levels of catabolic factors were increased. Then, serum cortisol level from IUGR individuals was found increased, and similar changes were observed in normal WJ-MSCs treated with excessive cortisol. Moreover, the decreased histone 3 lysine 9 acetylation (H3K9ac) level of TGFβRI and its expression were observed in IUGR-derived WJ-MSCs and normal WJ-MSCs treated with excessive cortisol, which could be abolished by RU486 and LMK235. At last, the decreased H3K9ac level of TGFβRI and its expression were further confirmed in the cartilage of IUGR rat offspring and human umbilical cords from IUGR newborn. CONCLUSIONS: WJ-MSCs from IUGR individuals displayed a poor capacity of chondrogenic differentiation and an increased susceptibility to osteoarthritis-like phenotype, which was attributed to the decreased H3K9ac level of TGFβRI and its expression induced by high cortisol through GR/HDAC4. The H3K9ac of TGFβRI in human umbilical cord could be a potential early-warning biomarker for predicting neonatal cartilage dysplasia and osteoarthritis susceptibility.
Authors: Ariann Crudo; Matthew Suderman; Vasilis G Moisiadis; Sophie Petropoulos; Alisa Kostaki; Michael Hallett; Moshe Szyf; Stephen G Matthews Journal: Endocrinology Date: 2013-02-06 Impact factor: 4.736
Authors: Yang Tan; Jin Liu; Yu Deng; Hong Cao; Dan Xu; Fenglong Cu; Youying Lei; Jacques Magdalou; Min Wu; Liaobin Chen; Hui Wang Journal: Toxicol Lett Date: 2012-09-17 Impact factor: 4.372
Authors: Christa Broholm; Anders H Olsson; Alexander Perfilyev; Ninna S Hansen; Maren Schrölkamp; Klaudia S Strasko; Camilla Scheele; Rasmus Ribel-Madsen; Brynjulf Mortensen; Sine W Jørgensen; Charlotte Ling; Allan Vaag Journal: Diabetologia Date: 2016-09-14 Impact factor: 10.122